Welcome back to Week in Review! Tons of news from this week for you, including a hacking group that's linked to the Spanish ...

Regeneron (NASDAQ: REGN) entered an agreement to acquire 23andMe for $256 million, which is a tiny fraction of its previous ...

Recapping some of the most talked-about news this week from the nation and around the world – in case you missed it.

Missouri Attorney General Andrew Bailey is alerting residents after biotechnology company 23andMe filed for bankruptcy in ...

Republican Sen. John Cornyn and Democratic Sen. Amy Klobuchar are rolling out a measure to protect sensitive genetic data ...

A crucial step in handling the sale of genetic data from over 15 million 23andMe customers now rests largely in the hands of ...

We recently published a list of Jim Cramer Reveals “Quiet” Stock That Goes Up In This List Of 12 Stocks. In this article, we ...

There is nothing more inherently unique and personal to an individual than his or her DNA. Unlike many other types of personal information, a ...

A 23AndMe spokesperson told Bloomberg that the website delays were due to heavy site traffic. This comes in the wake of the company's weekend bankruptcy filing. In other news: McCormick begins ...

The price tag of this acquisition suggests that the value of genetic data is declining. Back in 2018, the drug company GSK ...

Regeneron acquires bankrupt 23andMe for $256M, taking over its DNA database and services while pledging to uphold privacy ...

Regeneron Pharmaceuticals said it will acquire 23andMe's business. What happened to 23andMe? Should you delete your data?